Upstream Bio, Inc. UPB
NASDAQ · United States · Health Technology
$5.040.00 (0.00%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-11 | -0.73 | -0.74 | +1.9% | $773.00K | +79.3% | -7.1%$7.44→$6.91 |
| Q1 2026 | 2026-05-13 | -0.75 | -0.80 | +6.3% | — | — | -1.8%$8.95→$8.79 |
| Q4 2025 | 2026-03-26 | -0.78 | -0.70 | -11.4% | — | — | -8.4%$9.47→$8.67 |
| Q3 2025 | 2025-11-05 | -0.63 | -0.78 | +19.2% | — | — | -5.5%$25.04→$23.66 |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.